Galenica continues growth trajectory and confirms outlook for 2026
Galenica increases sales by 5.7% to CHF 3,172.0 million in the first nine months of 2026. The pharmacy business and home care are key contributors to growth.
Galenica maintains its track record of consistent growth
Galenica increases sales by 7.1% to CHF 2,136.5 million in the first half of 2026. Adjusted1 EBIT increases by 7.1% to CHF 117.7 million.
Ad hoc announcements
2026/05/28
Galenica posts strong sales growth in a challenging market environment
Galenica achieves sales growth of 7.3% to CHF 1,409.7 million in the first four months of 2026. The main driver is strong growth in the pharmacy business and wholesale.
Ad hoc announcements
2026/03/10
Galenica achieves strong annual result and increases mid-term guidance
Galenica increases sales in 2025 by 5.5% to CHF 4,135.6 million – all business areas contribute to growth.Adjusted1 EBIT increases by 11.3% to CHF 234.8 million.
Ad hoc announcements
2026/02/24
Galenica focuses Bichsel’s business on home care services
Bichsel intends to discontinue pharmaceutical production by the end of 2026 at the latest for economic reasons. This affects up to 170 jobs.
Ad hoc announcements
2026/01/22
Galenica continues to grow: sales increase to over CHF 4 billion
Sales up by 5.5% to CHF 4,135.
Ad hoc announcements
2025/10/23
Galenica remains on growth track
Galenica Group sales grew 4.7% to CHF 2,999.7 million in the third quarter of 2025.Sales growth is driven by prescription drugs and dietary supplements.
Ad hoc announcements
2025/08/07
Galenica demonstrates pleasing growth and improves EBIT guidance
Galenica Group sales grew by 5.0% to CHF 1,995.4 million in the first half of 2025.Adjusted EBIT1 increased by 10.9% to CHF 109.
Ad hoc announcements
2025/07/02
Galenica to enter the diagnostics business by acquiring Labor Team
By acquiring the Labor Team Group, Galenica is adding a leading Swiss diagnostic service provider to its healthcare network.
Ad hoc announcements
2025/05/22
Galenica continues sales growth
Sales growth of 4.7% to CHF 1,314.2 million Strong growth in all key business areas Guidance for 2025 confirmed – sales growth of 3-5% and EBIT1 growth of 4-6% expected
Ad hoc announcements
2025/03/11
Galenica continues to grow in 2024
With sales up 4.7% in the 2024 financial year, the Galenica Group grew strongly and generated consolidated net sales of CHF 3,921.1 million.
Ad hoc announcements
2025/01/23
Galenica reports strong sales growth once again
Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million.
Ad hoc announcements
2024/10/24
Galenica increases sales growth in the third quarter
Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.
Ad hoc announcements
2024/08/06
Galenica achieves solid growth in a challenging market environment
Galenica Group sales grew by 2.6% to CHF 1,900.0 million in the first half of 2024.
Ad hoc announcements
2024/05/23
Galenica on track with sales growth
The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024.
Ad hoc announcements
2024/03/12
Galenica continues to grow in the 2023 financial year
The Galenica Group achieved strong growth with an increase in sales of 4.4% in the 2023 financial year and generated consolidated net sales of CHF 3,746.0 million.
Ad hoc announcements
2024/01/18
Galenica again achieves strong sales growth
Galenica Group sales performed well in 2023, growing by 4.4% to CHF 3,746.0 million. As expected, sales growth of 3.
Ad hoc announcements
2023/10/24
Galenica Investor Day: Updated mid-term guidance and strategy update
Ad hoc announcements
2023/08/08
Galenica achieves strong sales growth in the first half of 2023
Ad hoc announcements
2023/07/25
Galenica lowers EBIT guidance 2023 due to special factors – Sales and dividend outlook confirmed
Ad hoc announcements
2023/05/11
Green light for Switzerland’s leading online pharmacy
Ad hoc announcements
2023/03/30
Galenica and Shop Apotheke Europe enter into a strategic partnership and establish the leading online pharmacy in Switzerland
Ad hoc announcements
2023/03/07
Galenica achieves strong results in 2022 and increases dividend again
Ad hoc announcements
2023/01/19
Change to the Board of Directors of the Galenica Group
@[VERFORA](urn:li:organization:11519544) übernimmt die Mehrheit des polnischen Distibutors @[Qpharma Sp. z o.o.](urn:li:organization:86470457) Die beiden …
𝗩𝗶𝗲𝗹𝗲 𝗧𝗮𝗹𝗲𝗻𝘁𝗲. 𝗩𝗶𝗲𝗹𝗲 𝗠ö𝗴𝗹𝗶𝗰𝗵𝗸𝗲𝗶𝘁𝗲𝗻. 𝗘𝗶𝗻 𝗡𝗲𝘁𝘇𝘄𝗲𝗿𝗸. Was haben das Innenleben eines Computers, die Versorgung einer Wunde und die Organisation eines …
Apotheken als Chance für die Gesundheitsversorgung Die Rolle der Apotheke hat sich in den vergangenen Jahren gewandelt. 🙏Darin liegt eine …
Ein Blick hinter die Kulissen der Versorgungssicherheit 🎬 Pflichtlager helfen, die Versorgung mit lebenswichtigen Medikamenten auch bei Engpässen …
Das Galenica-Netzwerk bleibt auf Wachstumskurs. Die ersten neun Monate 2026 zeigen erneut, wie die verschiedenen Bereiche unseres Netzwerks zur …
𝗟𝗮 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗶𝗲 𝗱𝗲 𝗱𝗲𝗺𝗮𝗶𝗻 𝘀𝗲 𝗱𝗲𝘀𝘀𝗶𝗻𝗲 𝗮𝘂𝗷𝗼𝘂𝗿𝗱’𝗵𝘂𝗶 💊 \| 𝗡𝗣𝗦𝗪 𝟮𝟬𝟮𝟲 À quoi ressemblera le quotidien des pharmaciennes et pharmaciens de demain ? Et comment …
𝗙𝗶𝗻𝗱 𝘆𝗼𝘂𝗿 𝗽𝗹𝗮𝗰𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗚𝗔𝗟𝗘𝗡𝗜𝘃𝗲𝗿𝘀𝗲 🚀 Une soirée dans les étoiles avec les étudiant/es en pharmacie de l’Université de Genève afin de leur faire …
Gestern durften wir 4 𝗷𝘂𝗻𝗴𝗲 𝗧𝗮𝗹𝗲𝗻𝘁𝗲 als Teil unseres 𝗧𝗿𝗮𝗶𝗻𝗲𝗲-𝗣𝗿𝗼𝗴𝗿𝗮𝗺𝗺𝘀 bei …
💜 Tag der Apotheke 💜 Gemeinsam stark für die Gesundheit unserer Kundinnen und Kunden! Wer an eine Apotheke denkt, denkt oft zuerst an Medikamente. …
💊Fünf Fussballfelder voller Medikamente – und ein System für den Ernstfall In Burgdorf lagern Millionen Medikamentenpackungen. Ein Teil davon ist für …
Arbeitswelten prägen uns: Wie arbeiten wir zusammen? Wie tauschen wir uns untereinander aus? Wie treiben wir Innovation voran? 🚀
Genau …
🎉 🏆L'entusiasmi dei clienti al centro dell'attenzione: due team ricevono il «Gali Award 2026»
Ieri, nell'ambito del Galenica Leadership …
🎉 🏆 L'enthousiasme des clients à l’honneur : Deux équipes reçoivent le Gali Award 2026.
C'est déjà la deuxième fois que nous avons …
🎉 🏆 Kundenbegeisterung im Fokus: Zwei Teams werden mit dem «Gali Award 2026» ausgezeichnet.
Bereits zum zweiten Mal haben wir gestern im …
Wir beteiligen uns an der neu grössten digitalen Gesundheitsplattform der Schweiz: @[COMPASSANA](urn:li:organization:81730524) und @[Well Gesundheit …
Unser Gesundheitsnetzwerk wächst mit hoher Kontinuität weiter.
Zeit für einen Blick zurück auf das erste Halbjahr 2026: Wir haben …
🧡 spot°115: Prestations de santé dans nos pharmacies – Coup d’œil dans les coulisses
Aujourd'hui, quand on entre dans une pharmacie, on y …
🧡 spot°115: Dienstleistungen in unseren Apotheken – Ein Blick hinter die Kulissen Wer heute eine Apotheke betritt, findet weit mehr als Medikamente. …